---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-086224"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T03:48:22.778291+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Select Medical Q2 net income falls 66% to $66.3M; EPS $0.43 vs $1.22

## Summary
- Revenue $1,584.7M (+1.3% YoY); net income $66.3M vs $196.2M; diluted EPS $0.43 vs $1.22.
- Adjusted EBITDA $181.0M vs $342.0M; includes $15.1M Provider Relief Fund income (prior year $98.0M).
- Critical illness recovery hospital segment Adjusted EBITDA plunged to $20.0M from $72.9M; margin 3.7% vs 13.4%.
- Board declared $0.125/share cash dividend payable Sept 2, 2022 to holders of record Aug 16, 2022.
- Reaffirms FY2022 revenue outlook $6.25B-$6.40B; defers Adjusted EBITDA/EPS guidance until labor market stabilizes.

## SEC filing metadata
- accession: 0001104659-22-086224
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465922086224/0001104659-22-086224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465922086224/tm2222622d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-086224
- JSON: https://secwatch.observer/filing/0001104659-22-086224.json
- Plain text: https://secwatch.observer/filing/0001104659-22-086224.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.